论文部分内容阅读
[目的]评价自控止痛泵应用于晚期癌症病人镇痛效果。[方法]对30例晚期癌症患者应用自控止痛泵治疗(实验组),氯诺昔康48mg,芬太尼0.5mg,托烷司琼4mg加生理盐水至总量100ml,输注速度2ml/h,自控0.5ml/次,锁定时间15min。对照组采用哌替啶50mg肌肉注射。[结果]实验组30例中,显效23例(占76.67%),有效5例(占16.66%),无效2例(占6.67%),总有效率为93.33%。对照组30例中,显效15例(占50.00%),有效12例(占40.00%),无效3例(占10.00%),总有效率为90.00%。实验组自我感觉舒适,生活质量较好。[结论]自控止痛泵可持续有效控制晚期癌症病人疼痛,提高患者的生存质量。
[Objective] To evaluate the analgesic effect of controlled analgesic pump in patients with advanced cancer. [Methods] Thirty patients with advanced cancer were treated with controlled analgesia pump (experimental group), lornoxicam 48mg, fentanyl 0.5mg, tropisetron 4mg plus normal saline to total volume 100ml, infusion rate 2ml / h , Controlled 0.5ml / time, lock time 15min. Control group using pethidine 50mg intramuscular injection. [Results] Among the 30 cases in the experimental group, 23 cases were markedly effective (76.67%), 5 cases were effective (16.66%), 2 cases were invalid (6.67%), and the total effective rate was 93.33%. The control group of 30 cases, markedly effective in 15 cases (50.00%), effective in 12 cases (40.00%), 3 cases (10.00%), the total effective rate was 90.00%. Experimental group feel comfortable, good quality of life. [Conclusion] The controlled analgesia pump can effectively and effectively control the pain of patients with advanced cancer and improve the quality of life of patients.